Key facts
- Notable investors include Miracleplus, Dalton Venture, Qijia Partners, Winzac Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Yuan Dong Bio
- ·The full record, as it builds
Funding rounds
No funding rounds for Yuan Dong Bio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Yuan Dong Bio
Developer of bio-engineered material production methods intended for petrochemical-based components. The company offers microbial-based manufacturing processes, AI-guided pathway design, customized strain engineering, and low-impact production paradigms, enabling manufacturers in electronics, advanced materials, consumer goods, and related sectors to integrate next-generation bio-based materials into large-scale industrial applications.
- Sector
- Healthcare
- HQ
- Guangzhou, China
- Founded
- 2024
- Website
- yuandong.bio/
- Ownership
- Privately Held (backing)
Yuan Dong Bio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Yuan Dong Bio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Yuan Dong Bio in its N-PORT filings yet. We sweep new filings monthly.